Role of Pathology in Diagnosis Flashcards
What is the most common benign breast neoplasm?
The most common benign breast neoplasm is a fibroadenoma.
What is the most common malignant breast neoplasm?
The most common malignant breast neoplasm is a breast carcinoma.
Give an example of a palpable difference between benign and malignant breast neoplasms.
What is the cause of this difference?
- Benign breast neoplasms are mobiel whereas malignant breast neoplasms are rarely mobile.
- This is because the malignant breast neoplasm is able to invade surrounding structures.
List the tissue layers of the colon in order from superficial to deep.
In which layer of the colon do the majority of neoplasms arise?
Why?
1 - Mucosa.
2 - Submucosa.
3 - Muscularis.
4 - Serosa.
- The majority of colon cancers arise in the mucosa. This is because:
1 - It is the region exposed to the highest concentration of carcinogens.
2 - It is the region with the highest turnover rate.
Which section of the colon is most commonly affected by colon carcinoma?
The sigmoid colon is the section of the colon which is most commonly affected by colon carcinoma.
Why might colon cancer cause a change in bowel habit?
- Colon cancer can be stenosing.
- This can slow the passage of the stool through the colon, allowing for more time for water reabsorption, causing constipation.
- It can also obstruct solid matter from passing through the colon whilst permitting liquids to pass, causing diarrhoea.
Which section of the colon is most commonly affected with a colon carcinoma that causes a change in bowel habit?
Why?
- Colon carcinomas affecting the sigmoid colon more commonly cause a change in bowel habit.
- This is because colon carcinomas of the sigmoid colon are more frequently stenosing, whereas colon carcinomas in the ascending colon are more frequently polypoid.
List 3 biopsy techniques.
For each technique, give an example of an area of the body for which the technique is commonly used.
1 - Endoscopic biopsy (e.g. GI tract and bronchi).
2 - Needle biopsy (many areas).
3 - Punch biopsy (e.g. skin).
*These can all be used to obtain specimens to investigate cancer.
List 4 techniques that are used to obtain cytology specimens.
1 - Smears.
2 - Endoscopic brushings.
3 - Bodily fluids.
4 - Fine needle aspiration.
*These can all be used to obtain specimens to investigate cancer.
List 4 purposes of pathological assessments of cancer.
1 - To confirm the diagnosis of a malignancy.
2 - To determine the aggressiveness (grade) of a cancer.
3 - To assess the extent of spread (staging) of a cancer.
4 - To examine the completeness of excision.
What is the most common distant site of spread of colorectal cancer?
Why?
- The most common distant site of spread of colorectal cancer is the liver.
- This is because the cancer is able to reach the liver directly by the hepatic portal vein.
How can an inflammatory infiltration be told apart from a neoplastic infiltration histologically?
- An inflammatory infiltration consists of a mixed population of cells.
- A neoplastic infiltration consists of a pure population of cells.
How are T lymphocytes told apart from B lymphocytes on a tissue specimen?
- T lymphocytes are tagged with CD3 antibodies.
- B lymphocytes are tagged with CD20 antibodies.
- The specimen is then examined using imaging.
Give an example of an immunohistochemical prognostic marker for cancer.
How does it work?
- The Ki-67 labelling index is used as a prognostic marker for cancer.
- It detects various components of the cell cycle.
- The higher the labelling, the more rapid the turn over, indicating high metastatic potential.
How can immunohistochemistry be used to identify therapeutic options for cancer?
- Expression of specific antigenic markers can be used to identify tumours that are likely to be amenable to specific therapies targeting the antigens expressed. For example:
1 - Breast carcinomas that express the growth factor HER2 can be treated with herceptin, a HER2 antagonist.
2 - Breast carcinomas that express the oestrogen receptor may be amenable to hormone therapy.
3 - GI stromal tumours expressing the tyrosine kinase receptor c-KIT can be treated with Gleevec, a tyrosine kinase inhibitor.
*Identifying mutations can also impact therapeutic options.